Total Payments
$1,996
2021 Payments
$352.51
Companies
23
Transactions
110
Medicare Patients
5,819
Medicare Billing
$318,694
Payment Breakdown by Category
Food & Beverage$1,993 (99.8%)
Consulting$3.40 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,993 | 109 | 99.8% |
| Consulting Fee | $3.40 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $291.70 | 20 | $0 (2021) |
| Amarin Pharma Inc. | $187.24 | 11 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $176.96 | 9 | $0 (2020) |
| AbbVie Inc. | $172.36 | 8 | $0 (2021) |
| Novo Nordisk Inc | $169.30 | 11 | $0 (2021) |
| Allergan, Inc. | $136.27 | 9 | $0 (2020) |
| GlaxoSmithKline, LLC. | $128.12 | 7 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $110.66 | 2 | $0 (2019) |
| Vertiflex, Inc. | $108.98 | 1 | $0 (2018) |
| Gilead Sciences Inc | $96.69 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $352.51 | 19 | AbbVie Inc. ($172.36) |
| 2020 | $253.42 | 16 | Amarin Pharma Inc. ($79.83) |
| 2019 | $301.91 | 22 | PFIZER INC. ($91.02) |
| 2018 | $484.46 | 26 | Vertiflex, Inc. ($108.98) |
| 2017 | $603.80 | 27 | Merck Sharp & Dohme Corporation ($157.02) |
All Payment Transactions
110 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/19/2021 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Endocrinology | ||||||
| 07/06/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Diabetes Care | ||||||
| 06/24/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Cardiovascular | ||||||
| 06/23/2021 | PFIZER INC. | COLOGUARD DNA CAPTURE REAGENTS (Device), REYVOW | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: GASTROINTESTINAL | ||||||
| 06/16/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: NEUROSCIENCE | ||||||
| 05/20/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Gastroenterology | ||||||
| 05/12/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: Cardiovascular | ||||||
| 05/03/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Diabetes | ||||||
| 05/01/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: NEUROSCIENCE | ||||||
| 04/09/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.86 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Cardiovascular | ||||||
| 03/17/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Diabetes | ||||||
| 02/24/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.74 | General |
| Category: NEUROSCIENCE | ||||||
| 02/17/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: Cardiovascular | ||||||
| 02/03/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: NEUROSCIENCE | ||||||
| 01/14/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $29.39 | General |
| Category: NEUROSCIENCE | ||||||
| 01/14/2021 | KVK-Tech, Inc. | — | Consulting Fee | Cash or cash equivalent | $3.40 | General |
| 11/23/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Cardiovascular | ||||||
| 11/06/2020 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $13.39 | General |
| Category: Neurology | ||||||
| 10/28/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Cardiovascular | ||||||
| 09/29/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 755 | 982 | $147,884 | $40,858 |
| 2022 | 9 | 971 | 1,174 | $143,106 | $46,499 |
| 2021 | 20 | 1,754 | 2,325 | $211,062 | $77,507 |
| 2020 | 35 | 2,339 | 3,080 | $286,253 | $153,830 |
Total Patients
5,819
Total Services
7,561
Medicare Billing
$318,694
Procedure Codes
76
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 157 | 275 | $60,555 | $12,872 | 21.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 129 | 193 | $30,773 | $8,019 | 26.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 156 | 156 | $35,188 | $7,704 | 21.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 14 | 15 | $6,371 | $4,224 | 66.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 36 | 40 | $4,935 | $3,005 | 60.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 38 | 42 | $2,710 | $1,326 | 48.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 109 | 144 | $1,950 | $1,136 | 58.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 38 | 38 | $1,210 | $703.76 | 58.2% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 33 | 33 | $1,051 | $611.16 | 58.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 17 | 17 | $1,700 | $579.18 | 34.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 16 | 17 | $1,089 | $536.52 | 49.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 12 | $352.00 | $142.32 | 40.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 165 | 165 | $37,110 | $14,019 | 37.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 149 | 228 | $50,133 | $12,751 | 25.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 187 | 278 | $42,648 | $12,331 | 28.9% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 193 | 200 | $5,996 | $3,711 | 61.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 118 | 118 | $3,614 | $2,206 | 61.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 11 | $1,075 | $434.88 | 40.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 14 | 14 | $860.00 | $422.76 | 49.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 111 | 137 | $1,050 | $407.04 | 38.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 23 | 23 | $620.00 | $216.30 | 34.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 357 | 726 | $84,154 | $32,834 | 39.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 256 | 256 | $45,105 | $14,383 | 31.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 171 | 226 | $38,301 | $11,420 | 29.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 264 | 264 | $7,656 | $5,056 | 66.0% |
About Dr. Bruce Barniville, MD
Dr. Bruce Barniville, MD is a Internal Medicine healthcare provider based in Jupiter, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1598758104.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Barniville, MD has received a total of $1,996 in payments from pharmaceutical and medical device companies, with $352.51 received in 2021. These payments were reported across 110 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,993).
As a Medicare-enrolled provider, Barniville has provided services to 5,819 Medicare beneficiaries, totaling 7,561 services with total Medicare billing of $318,694. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Jupiter, FL
- Active Since 08/30/2005
- Last Updated 02/19/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1598758104
Products in Payments
- UBRELVY (Drug) $218.28
- Vascepa (Drug) $187.24
- BELSOMRA (Drug) $143.08
- ENTRESTO (Drug) $110.66
- Superion ISS (Device) $108.98
- PREVNAR - 13 (Biological) $104.72
- CHANTIX (Drug) $101.55
- XIFAXAN (Drug) $97.45
- Epclusa (Drug) $96.69
- Ozempic (Drug) $89.64
- ADVAIR (Drug) $66.16
- Victoza (Drug) $66.08
- SYMBICORT (Drug) $62.50
- SHINGRIX (Biological) $49.38
- LINZESS (Drug) $44.44
- MYRBETRIQ (Drug) $39.74
- VIAGRA (Drug) $39.08
- JANUVIA (Drug) $30.19
- SUPERION (Device) $29.20
- XARELTO (Drug) $23.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Jupiter
Dr. Naveen Reddy, Md, MD
Internal Medicine — Payments: $157,805
Internal Medicine $157,805
Hector Florentino
Internal Medicine — Payments: $27,870
Internal Medicine $27,870
Alexandra Berger, M.d, M.D
Internal Medicine — Payments: $11,580
Internal Medicine $11,580
Kevin Green, M.d, M.D
Internal Medicine — Payments: $11,076
Internal Medicine $11,076
Dr. Avishai Mendelson, Md, MD
Internal Medicine — Payments: $9,798
Internal Medicine $9,798
Isabel Bueno, M.d, M.D
Internal Medicine — Payments: $9,448
Internal Medicine $9,448